Compugen (CGEN) Non Operating Income (2009 - 2026)

Compugen (CGEN) reported Non Operating Income of $1.4 million for Q1 2026, up 8.67% on a YoY basis from $1.2 million in Q1 2025, and up 68.7% sequentially from $802000.0 in Q4 2025.

Compugen (CGEN) Non Operating Income (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 18 years of Non Operating Income data on file, last reported at $1.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income rose 8.67% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 19.62% YoY), and the FY2025 full-year result was $4.1 million, down 21.44% from the prior year.
  • Non Operating Income climbed to $1.4 million in Q1 2026, from $802000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.4 million in Q4 2024 to a low of $286000.0 in Q1 2022.
  • A 5-year average of $914823.5 and a median of $889000.0 in 2023 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income surged 266.67% in 2022 and tumbled 41.46% in 2025, its largest moves.
  • Tracing CGEN's Non Operating Income over 5 years: stood at $495000.0 in 2022, then soared by 48.48% to $735000.0 in 2023, then surged by 86.39% to $1.4 million in 2024, then plunged by 41.46% to $802000.0 in 2025, then soared by 68.7% to $1.4 million in 2026.
  • Business Quant data shows CGEN's Non Operating Income at $1.4 million in Q1 2026, $802000.0 in Q4 2025, and $954000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Compugen 215.59 Mn 123.84 Mn 352,000.00 1.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.35 Mn
Dec 31, 2025 802,000.00
Sep 30, 2025 954,000.00
Jun 30, 2025 1.07 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 1.23 Mn
Dec 31, 2023 735,000.00
Sep 30, 2023 776,000.00
Jun 30, 2023 889,000.00
Mar 31, 2023 808,000.00
Dec 31, 2022 495,000.00
Sep 30, 2022 464,000.00
Jun 30, 2022 493,000.00
Mar 31, 2022 286,000.00
Dec 31, 2021 135,000.00
Sep 30, 2021 177,000.00
Jun 30, 2021 200,000.00